Research programme: heparanase inhibitors - Dr Reddy's Laboratories
Alternative Names: DRF 8439; Heparanase inhibitors research programme - Dr Reddy's LaboratoriesLatest Information Update: 04 Aug 2010
At a glance
- Originator Dr Reddys Laboratories
- Class
- Mechanism of Action Heparanase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Solid tumours
Most Recent Events
- 14 Apr 2004 Preclinical trials in Solid tumours in India (unspecified route)
- 14 Apr 2004 Preclinical trials in Solid tumours in USA (unspecified route)